when did glp 1 drugs become popular Glucagon-like peptide-1 receptor: mechanisms and advances in therapy GLP-1 Receptor Agonist Market Size

Recent studies...

Research on the experimental drug petrelintide suggests it is much less likely to cause nausea and vomiting than GLP-1 drugs, but the pace of weight loss is more moderate.

For best results, we recommend 3-6 months of consistent daily use

Adolescents with obesity prescribed a GLP-1 receptor agonist are less likely to have suicidal ideation or a suicide attempt than those with obesity treated with lifestyle intervention, according to new data

Ozempic is the hottest drug on the market for weight loss

Understanding response variabilityinformed by biomarkers and genetic contextcan help guide conversations with healthcare providers about optimization strategies